Share the post "Oxygenta Pharmaceutical’s IPO Launches Takeover 08-08-2024!"
Oxygenta Pharmaceutical IPO of Takeover type offers an equity issue (inclusive of premium) with a face value of ₹ 10.00. The issue is live from 08 Aug 2024 to 22 Aug 2024 , with a market lot of 1 shares. This call notice includes , covering ₹10.00 towards face value and the remaining towards securities premium. This is a chance to invest in a well-established company known for its quality and innovation.
| Security Name | OXYGENTA PHARMACEUTICAL LTD |
|---|---|
| Offer Price () | 16.00 |
| Face Value | 10.00 |
| Type Of Issue | Takeover |
| Issue Status | Forthcoming |
| Scripname | OXYGENTA PHARMACEUTICAL LTD |
| Security Type | Equity |
| Symbol | OXYGENTAPH |
| Issue Type | Takeover |
| Issue Period | 08 Aug 2024 to 22 Aug 2024 |
| Tick Price | 0.01 |
| Market Lot | 1 |
| Book Size – No. Of Shares | 96,16,000 |
| Minimum Offer Quantity | 1 |
| Maximum Offer Quantity | 96,16,000 |
| Floor Price/Offer Price | 16.00 |
| Indicative Price | |
| Cummulative Bid Quantity | – |
| Name Of Acquirer(s)/Company | Mr. M V S Prasad Reddy (alias Mr. Mallu Venkata Siva Prasad Reddy) (“ACQUIRER”) |
| Buyer Member | S W Capital Private Ltd |
| Book Running Lead Manager | Mark Corporate Advisors Private Limited |
| Registrar | Venture Capital & Corporate Investments Private Limited |
| Exchange Notices | 1) Opening of Offer to Buy – Acquisition Window (Takeover) of OXYGENTA PHARMACEUTICAL LIMITED.2) Settlement Schedule Offer to Buy – Acquisition Window (Takeover) for OXYGENTA PHARMACEUTICAL LIMITED. |
Oxygenta Pharmaceutical IPO opens on 08-08-2024, and closes on 22-08-2024
| Start Date | 08-08-2024 |
|---|---|
| End Date | 22-08-2024 |
| Issue Period | 08 Aug 2024 to 22 Aug 2024 |
